scholarly journals Effectiveness of Deferred Combined Androgen Blockade Therapy Predicts Efficacy in Abiraterone Acetate Treated Metastatic Castration-Resistant Prostate Cancer Patients after Docetaxel

2017 ◽  
Vol 8 ◽  
Author(s):  
Jian-Ri Li ◽  
Kun-Yuan Chiu ◽  
Shian-Shiang Wang ◽  
Cheng-Kuang Yang ◽  
Chuan-Shu Chen ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
Abiraterone Acetate ◽  
Castration Resistant Prostate Cancer ◽  
Combined Androgen Blockade ◽  
Castration Resistant ◽  
Androgen Blockade

scholarly journals Enzalutamide in Combination with Abiraterone Acetate in Bone Metastatic Castration-resistant Prostate Cancer Patients

2020 ◽  
Vol 3 (1) ◽  
pp. 119-127 ◽  
Author(s):  
Eleni Efstathiou ◽  
Mark Titus ◽  
Sijin Wen ◽  
Patricia Troncoso ◽  
Anh Hoang ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
Abiraterone Acetate ◽  
Castration Resistant Prostate Cancer ◽  
Castration Resistant

Azacitidine for castration-resistant prostate cancer progressing on combined androgen blockade

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 5172-5172 ◽  
Author(s):  
G. Sonpavde ◽  
A. M. Aparicio ◽  
R. Delaune ◽  
L. E. Garbo ◽  
S. R. Rousey ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Castration Resistant Prostate Cancer ◽  
Combined Androgen Blockade ◽  
Castration Resistant ◽  
Androgen Blockade

The hematologic parameters in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate

2019 ◽  
Vol 15 (13) ◽  
pp. 1469-1479 ◽  
Author(s):  
Cem Onal ◽  
Ali Murat Sedef ◽  
Fatih Kose ◽  
Ezgi Oymak ◽  
Ozan Cem Guler ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
Abiraterone Acetate ◽  
Castration Resistant Prostate Cancer ◽  
Castration Resistant
Sign in / Sign up

Export Citation Format

Share Document